{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-080683","form_type":"8-K","ticker":"ORIC","cik":"0001796280","company_name":"Oric Pharmaceuticals, Inc.","filed_at":"2022-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.256327+00:00","generated_at":"2026-06-26T21:28:00.586849+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"ORIC Pharmaceuticals hosts Q4/FY2021 call; corporate presentation furnished as Exhibit 99.1","bullets":["Company held conference call on March 21, 2022 to discuss Q4 and full year 2021 financial results and operational update.","Corporate presentation attached as Exhibit 99.1 but specific financial figures are not included in the filing text.","Filing under Item 7.01 Regulation FD; presentation is furnished, not filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-080683","json":"https://secwatch.observer/filing/0001193125-22-080683.json","markdown":"https://secwatch.observer/filing/0001193125-22-080683.md","text":"https://secwatch.observer/filing/0001193125-22-080683.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796280/000119312522080683/0001193125-22-080683-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796280/000119312522080683/d337066d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T21:28:00.586849+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}